ORAMED PHARMACEUTICALS INC. Human Resources Contracts & Agreements
45 Contracts & Agreements
- Bonus & Incentive Agreements (4 contracts)
- Consulting Agreements (15)
- Employment Agreements (26)
- Employment Agreement, dated June 6, 2024, between Oramed Ltd. and Avraham Gabay (Filed With SEC on August 14, 2024)
- Fourth Amendment, dated January 8, 2024, to Employment Agreement, by and between Oramed Ltd. and David Silberman (Filed With SEC on March 6, 2024)
- Third Amendment, dated April 27, 2023, to Employment Agreement, by and between Oramed Ltd. and David Silberman (Filed With SEC on March 6, 2024)
- Amendment, dated January 8, 2024, to Consulting Agreements by and between Oramed Ltd. and KNRY, Ltd., entered into as of July 1, 2008, for the services of Miriam Kidron (Filed With SEC on March 6, 2024)
- Amendment, dated April 27, 2023, to Consulting Agreements by and between Oramed Ltd. and KNRY, Ltd., entered into as of July 1, 2008, for the services of Miriam Kidron (Filed With SEC on March 6, 2024)
- Amendment, dated January 8, 2024, to Employment Agreement by and between Oramed Ltd. and Nadav Kidron, entered into as of November 1, 2022 (Filed With SEC on March 6, 2024)
- Amendment, dated April 27, 2023, to Employment Agreement by and between Oramed Ltd. and Nadav Kidron, entered into as of November 1, 2022 (Filed With SEC on March 6, 2024)
- Amendment, dated January 8, 2024, to Consulting Agreement by and between Oramed Pharmaceuticals Inc. and Shnida Ltd., entered into as of November 1, 2022, for the services of... (Filed With SEC on March 6, 2024)
- Amendment, dated April 27, 2023, to Consulting Agreement by and between Oramed Pharmaceuticals Inc. and Shnida Ltd., entered into as of November 1, 2022, for the services of Nadav... (Filed With SEC on March 6, 2024)
- Oravax Medical, Inc. 2021 Long-Term Incentive Plan (Filed With SEC on March 6, 2023)
- Second Amendment, dated October 25, 2022, to Employment Agreement, by and between Oramed Ltd. and David Silberman (Filed With SEC on March 6, 2023)
- Employment Agreement by and between Oramed Ltd. and Nadav Kidron, entered into as of November 1, 2022 (Filed With SEC on March 6, 2023)
- Consulting Agreement by and between Oramed Pharmaceuticals Inc. and Shnida Ltd., entered into as of November 1, 2022, for the services of Nadav Kidron (Filed With SEC on March 6, 2023)
- First Amendment, dated September 19, 2021, to Employment Agreement, by and between Oramed Ltd. and Joshua Hexter (Filed With SEC on November 24, 2021)
- First Amendment, dated September 19, 2021, to Employment Agreement, by and between Oramed Ltd. and David Silberman (Filed With SEC on November 24, 2021)
- Employment Agreement, dated July 25, 2021, by and between the Company and Michael Rabinowitz (Filed With SEC on November 24, 2021)
- Amendment, dated September 19, 2021, to Consulting Agreements by and between Oramed Ltd. and KNRY, Ltd., entered into as of July 1, 2008, for the services of Miriam Kidron (Filed With SEC on November 24, 2021)
- Amendment, dated September 19, 2021, to Consulting Agreements by and between Oramed Ltd. and KNRY, Ltd., entered into as of July 1, 2008, for the services of Nadav Kidron (Filed With SEC on November 24, 2021)
- Employment Agreement, dated May 23, 2021, between Oramed Ltd. and David Silberman (Filed With SEC on July 14, 2021)
- Second Amendment, dated February 8, 2021, to Employment Agreement, entered into as of May 16, 2019, by and between Oramed Ltd. and Avraham Gabay (Filed With SEC on April 13, 2021)
- First Amendment, dated December 19, 2019, to Employment Agreement, entered into as of May 16, 2019, by and between Oramed Ltd. and Avraham Gabay (Filed With SEC on January 9, 2020)
- Employment Agreement, dated August 18, 2019, between Oramed Ltd. and Joshua Hexter (Filed With SEC on November 27, 2019)
- Employment Agreement, dated May 16, 2019, between Oramed Ltd. and Avraham Gabay (Filed With SEC on July 10, 2019)
- Consulting Agreement, dated December 12, 2018, between Oramed Ltd. and Joshua Hexter (Filed With SEC on January 14, 2019)
- Employment Agreement, dated November 6, 2018, by and between Oramed Ltd. and Mark Hasleton (Filed With SEC on November 28, 2018)
- Amendment to Amended and Restated Employment Agreement, dated October 29, 2018, by and between Oramed Ltd. and Hilla Eisenberg (Filed With SEC on November 28, 2018)
- Amendment to Employment Agreement, dated April 15, 2018, between Oramed Ltd. and Joshua Hexter (Filed With SEC on July 12, 2018)
- Amended and Restated Employment Agreement, dated July 20, 2017, between Oramed Ltd. and Hilla Eisenberg (Filed With SEC on July 21, 2017)
- Consulting Agreement (Filed With SEC on March 21, 2017)
- FourthAmendment to Employment Agreement (Filed With SEC on January 11, 2017)
- SecondAmendment to Employment Agreement (Filed With SEC on November 25, 2016)
- Amendment to Employment Agreement (Filed With SEC on November 25, 2015)
- Third Amendment to Employment Agreement (Filed With SEC on November 25, 2015)
- Second Amendment to Employment Agreement (Filed With SEC on November 25, 2015)
- ORAMED PHARMACEUTICALS INC. AMENDED AND RESTATED 2008 STOCK INCENTIVE PLAN Restricted Stock Unit Notice (Filed With SEC on November 14, 2014)
- AMENDMENT TO CONSULTING AGREEMENTS SIGNED IN JULY 1, 2008 (Filed With SEC on November 14, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on April 16, 2013)
- CONSULTING SERVICESAGREEMENT (Filed With SEC on April 22, 2009)
- ORAMED PHARMACEUTICALS INC. 2008 STOCK INCENTIVE PLAN NOTICE OF STOCK OPTION AWARD (Filed With SEC on July 2, 2008)
- Amendment, dated June 30, 2017, to Consulting Agreements by and between Oramed Ltd. and KNRY, Ltd., entered into as of July 1, 2008, for the services of Miriam Kidron (Filed With SEC on November 29, 2017)
